Semaglutide 0.5mg Pen Injection is a once-weekly injectable GLP-1 receptor agonist containing semaglutide 0.5mg. It is administered by subcutaneous injection and may be used as part of treatment for type 2 diabetes mellitus or chronic weight management, depending on the specific semaglutide product and its approved indication.
The 0.5mg strength is an established injectable semaglutide dose. Current U.S. product information lists semaglutide 0.5mg/0.5mL in a single-dose prefilled pen, while established Wegovy dosing information uses 0.5mg once weekly during dose escalation.
Semaglutide 0.5mg Pen Injection contains 0.5mg of semaglutide, a long-acting GLP-1 receptor agonist administered by subcutaneous injection.
The 0.5mg strength is available in established semaglutide prefilled pen formulations. U.S. Wegovy labeling lists a 0.5mg/0.5mL single-dose pen, with each pen delivering one 0.5mg dose.
Semaglutide injection products are prescribed according to their individual approved indications, which can include type 2 diabetes management or chronic weight management.
Semaglutide activates GLP-1 receptors, which play an important role in glucose regulation and appetite control.
It can help:
Depending on the specific product and regulatory approval, Semaglutide 0.5mg Pen Injection may be prescribed for:
The 0.5mg strength may form part of a gradual dose-escalation schedule for injectable semaglutide.
For example, current Wegovy prescribing information uses 0.25mg once weekly during weeks 1–4 followed by 0.5mg once weekly during weeks 5–8, before further dose escalation where appropriate.
The correct dose and duration of treatment depend on the specific product, indication, individual response and healthcare professional’s instructions.
Wegovy® is a branded semaglutide injection. Its current U.S. product information lists 0.5mg/0.5mL as an available single-dose pen strength.
A Semaglutide 0.5mg Pen from another manufacturer may contain the same active ingredient and strength but can differ in manufacturer, device, formulation, packaging and regulatory authorization.
Ozempic® is another branded semaglutide injection used primarily in the treatment of type 2 diabetes.
Because both products contain semaglutide, searches for Semaglutide 0.5mg Injection, Ozempic 0.5mg, Generic Ozempic 0.5mg and Generic Semaglutide 0.5mg can overlap commercially.
However, branded products have their own approved indications and prescribing information.
Generic Semaglutide 0.5mg refers to a semaglutide injection manufactured and marketed by a pharmaceutical company other than the reference-brand manufacturer, where such generic or equivalent marketing is authorized.
For commercial searches, the product can target:
Semaglutide 0.5mg Pen Injection may be available through licensed pharmacies and pharmaceutical suppliers in markets where the product is authorized.
Customers searching for Semaglutide 0.5mg Pen Injection, Semaglutide 0.5mg Injection, Generic Semaglutide 0.5mg, Buy Semaglutide 0.5mg, Semaglutide 0.5mg Price, Generic Wegovy 0.5mg, Generic Ozempic 0.5mg and related terms can check product availability, pricing and ordering options through licensed pharmaceutical suppliers.
Prescription requirements, importation rules and availability vary by country.
Semaglutide 0.5mg Pen Injection is a subcutaneous injectable medicine containing 0.5mg of semaglutide, a GLP-1 receptor agonist.
Depending on the specific product and approved indication, semaglutide injection may be used for type 2 diabetes management or chronic weight management.
Yes. Semaglutide is a GLP-1 receptor agonist.
Established semaglutide injection products such as Wegovy are administered once weekly. The specific product should always be used according to its prescribing information.
The 0.5mg strength is generally used after an initial lower dose in established dose-escalation regimens. For Wegovy, 0.5mg follows the 0.25mg starting dose during weeks 5–8.
Both contain semaglutide at the 0.5mg strength, but Wegovy is a specific branded product. A generic semaglutide product may have a different manufacturer, device and regulatory status.
Both are semaglutide injection products, but they are different branded or generic products and may have different approved indications and labeling.
Semaglutide injection is prescription medicine. Online availability depends on local regulations and prescription requirements. Purchase prescription medicines only through appropriately licensed pharmaceutical suppliers.
Use Semaglutide 0.5mg exactly as prescribed. Established injectable semaglutide products are administered subcutaneously, generally once weekly.
Gastrointestinal effects such as nausea, vomiting, diarrhea, constipation and abdominal discomfort can occur. Consult a healthcare professional for advice about persistent or severe symptoms.
Contraindications depend on the specific product. Current U.S. Wegovy labeling includes a personal or family history of medullary thyroid carcinoma or MEN 2 and serious hypersensitivity to semaglutide or its excipients among contraindications.
Medical Disclaimer: This product information is provided for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Semaglutide is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Product indications, dosing, contraindications and availability may vary by manufacturer and country.
Last Updated: August 23, 2026
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Semaglutide 0.5mg Pen Injection
Reviews
There are no reviews yet